Terms: = Kidney tumors AND HLF, Q16534, 3131, ENSG00000108924 AND Treatment
4 results:
1. [Oncological results of repeat partial nephrectomy in patients with recurrence after nephron-sparing procedures].
Matveev V B; Zhumabaev N K; Komarov M I; Klimov A V; Stilidi I S
Urologiia; 2024 Mar; (1):86-91. PubMed ID: 38650411
[TBL] [Abstract] [Full Text] [Related]
2. Antitumor activity of a hydrogel loaded with lipophilic bismuth nanoparticles on cervical, prostate, and colon human cancer cells.
Cabral-Romero C; Solís-Soto JM; Sánchez-Pérez Y; Pineda-Aguilar N; Meester I; Pérez-Carrillo E; Nakagoshi-Cepeda SE; Sánchez-Nájera RI; Nakagoshi-Cepeda MAA; Hernandez-Delgadillo R; Chellam S; García-Cuéllar CM
Anticancer Drugs; 2020 Mar; 31(3):251-259. PubMed ID: 31764012
[TBL] [Abstract] [Full Text] [Related]
3. Mechanisms of enhanced tumoricidal efficacy of multiple small dosages of ranpirnase, the novel cytotoxic ribonuclease, on lung cancer.
Lee I; Shogen K
Cancer Chemother Pharmacol; 2008 Jul; 62(2):337-46. PubMed ID: 18064463
[TBL] [Abstract] [Full Text] [Related]
4. [Preliminary clinical comparison of hlf and ELF regimen in the treatment of advanced gastric carcinoma in middle-aged and elderly patients].
Xiong X; Zhu Z; Wen Z
Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):411-3. PubMed ID: 11778280
[TBL] [Abstract] [Full Text] [Related]